skip to main content
Idioma:
Resultados 1 2 next page
Refinado por: xxx: xxx remover Oncogene remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
SMURF2 prevents detrimental changes to chromatin, protecting human dermal fibroblasts from chromosomal instability and tumorigenesis
SMURF2 prevents detrimental changes to chromatin, protecting human dermal fibroblasts from chromosomal instability and tumorigenesis
Material Type:
Artigo 		Adicionar ao Meu Espaço

SMURF2 prevents detrimental changes to chromatin, protecting human dermal fibroblasts from chromosomal instability and tumorigenesis

Manikoth Ayyathan, Dhanoop ; Koganti, Praveen ; Marcu-Malina, Victoria ; Litmanovitch, Talia ; Trakhtenbrot, Luba ; Emanuelli, Andrea ; Apel-Sarid, Liat ; Blank, Michael

Oncogene, 2020-04, Vol.39 (16), p.3396-3410 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis
Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis
Material Type:
Artigo 		Adicionar ao Meu Espaço

Stabilization of FASN by ACAT1-mediated GNPAT acetylation promotes lipid metabolism and hepatocarcinogenesis

Gu, Li ; Zhu, Yahui ; Lin, Xi ; Tan, Xingyu ; Lu, Bingjun ; Li, Youjun

Oncogene, 2020-03, Vol.39 (11), p.2437-2449 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
3
VEGF.sub.165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a [beta]1 integrin/VEGFR autocrine loop
VEGF.sub.165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a [beta]1 integrin/VEGFR autocrine loop
Material Type:
Artigo 		Adicionar ao Meu Espaço

VEGF.sub.165b, a splice variant of VEGF-A, promotes lung tumor progression and escape from anti-angiogenic therapies through a [beta]1 integrin/VEGFR autocrine loop

Boudria, Asma ; Abou Faycal, Cherine ; Jia, Tao ; Gout, Stephanie ; Keramidas, Michelle ; Didier, Chloé ; Lemaître, Nicolas

Oncogene, 2019-02, Vol.38 (7), p.1050 [Periódico revisado por pares]

Nature Publishing Group

Texto completo disponível

Citações Citado por
4
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner
Material Type:
Artigo 		Adicionar ao Meu Espaço

Heterogeneous cancer-associated fibroblast population potentiates neuroendocrine differentiation and castrate resistance in a CD105-dependent manner

Kato, Manabu ; Placencio-Hickok, Veronica R ; Madhav, Anisha ; Haldar, Subhash ; Tripathi, Manisha ; Billet, Sandrine ; Mishra, Rajeev ; Smith, Bethany ; Rohena-Rivera, Krizia ; Agarwal, Priyanka ; Duong, Frank ; Angara, Bryan ; Hickok, David ; Liu, Zhenqiu ; Bhowmick, Neil A

Oncogene, 2019-01, Vol.38 (5), p.716-730 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
5
Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer
Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Serine-arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer

Mavrou, A ; Brakspear, K ; Hamdollah-Zadeh, M ; Damodaran, G ; Babaei-Jadidi, R ; Oxley, J ; Gillatt, D A ; Ladomery, M R ; Harper, S J ; Bates, D O ; Oltean, S

Oncogene, 2015-08, Vol.34 (33), p.4311-4319 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
6
Hallmarks of alternative splicing in cancer
Hallmarks of alternative splicing in cancer
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hallmarks of alternative splicing in cancer

Oltean, S ; Bates, D O

Oncogene, 2014-11, Vol.33 (46), p.5311-5318 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
7
GSK3[beta] phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21
GSK3[beta] phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21
Material Type:
Artigo 		Adicionar ao Meu Espaço

GSK3[beta] phosphorylation of the KLF6 tumor suppressor promotes its transactivation of p21

Lang, U E ; Kocabayoglu, P ; Cheng, G Z ; Ghiassi-nejad, Z ; Muñoz, U ; Vetter, D ; Eckstein, D A ; Hannivoort, R A ; Walsh, M J ; Friedman, S L

Oncogene, 2013-09, Vol.32 (38), p.4557 [Periódico revisado por pares]

New York: Nature Publishing Group

Texto completo disponível

Citações Citado por
8
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
Material Type:
Artigo 		Adicionar ao Meu Espaço

miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis

Catuogno, S ; Cerchia, L ; Romano, G ; Pognonec, P ; Condorelli, G ; de Franciscis, V

Oncogene, 2013-01, Vol.32 (3), p.341-351 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
9
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo
The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo
Material Type:
Artigo 		Adicionar ao Meu Espaço

The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo

Merdzhanova, G ; Gout, S ; Keramidas, M ; Edmond, V ; Coll, J-L ; Brambilla, C ; Brambilla, E ; Gazzeri, S ; Eymin, B

Oncogene, 2010-09, Vol.29 (39), p.5392-5403 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível

Citações Citado por
10
Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma
Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Insulin-like growth factor binding protein-3 (IGFBP-3) acts as an invasion-metastasis suppressor in ovarian endometrioid carcinoma

TORNG, P.-L ; LEE, Y.-C. G ; HUANG, C.-Y. F ; YE, J.-H ; LIN, Y.-S ; CHU, Y.-W ; HUANG, S.-C ; COHEN, P ; WU, C.-W ; LIN, C.-T

Oncogene, 2008-04, Vol.27 (15), p.2137-2147 [Periódico revisado por pares]

Basingstoke: Nature Publishing

Texto completo disponível

Citações Citado por
Resultados 1 2 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.